VALENZA, MARTA
VALENZA, MARTA
Dipartimento di Bioscienze
A gene network regulating lysosomal biogenesis and function
2009 M. Sardiello, M. Palmieri, A. di Ronza, D.L. Medina, M. Valenza, V.A. Gennarino, C. Di Malta, F. Donaudy, V. Embrione, R.S. Polishchuk, S. Banfi, G. Parenti, E. Cattaneo, A. Ballabio
ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease
2021 F. Cozzolino, E. Vezzoli, C. Cheroni, D. Besusso, P. Conforti, M. Valenza, I. Iacobucci, V. Monaco, G. Birolini, M. Bombaci, A. Falqui, P. Saftig, R.L. Rossi, M. Monti, E. Cattaneo, C. Zuccato
An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin
2012 V. Lo Sardo, C. Zuccato, G. Gaudenzi, B. Vitali, C. Ramos, M. Tartari, M.A. Myre, J.A. Walker, A. Pistocchi, L. Conti, M. Valenza, B. Drung, B. Schmidt, J. Gusella, S. Zeitlin, F. Cotelli, E. Cattaneo
Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease
2010 M. Marullo, M. Valenza, C. Mariotti, S. Di Donato, E. Cattaneo, C. Zuccato
Brain-derived neurotrophic factor in patients with Huntington's disease
2011 C. Zuccato, M. Marullo, B. Vitali, A. Tarditi, C. Mariotti, M. Valenza, N. Lahiri, E.J. Wild, J. Sassone, A. Ciammola, A.C. Bachoud-Lèvi, S.J. Tabrizi, S. Di Donato, E. Cattaneo
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation
2007 M. Valenza, J.B. Carroll, V. Leoni, L.N. Bertram, I. Björkhem, R.R. Singaraja, S. Di Donato, D. Lutjohann, M.R. Hayden, E. Cattaneo
Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes
2010 M. Valenza, V. Leoni, J.M. Karasinska, L. Petricca, J. Fan, J. Carroll, M.A. Pouladi, E. Fossale, H.P. Nguyen, O. Riess, M. Macdonald, C. Wellington, S. Didonato, M. Hayden, E. Cattaneo
Cholesterol dysfunction in neurodegenerative diseases : is Huntington's disease in the list?
2006 E. Cattaneo, M. Valenza
Cholesterol-laden brain-permeable nanoparticles support long-lasting cognitive recovery and motor amelioration in the slow-progressing zQ175DN mouse model of Huntington’s Disease
2022 G. Birolini, M. Valenza, I. Ottonelli, F. Talpo, L. Minoli, A. Cappelleri, M. Bombaci, C. Caccia, V. Leoni, A. Passoni, M. Favagrossa, M.R. Nucera, L. Colombo, S. Paltrinieri, R. Bagnati, J. Thomas Duskey, R. Caraffi, M. Angela Vandelli, F. Taroni, M. Salmona, E. Scanziani, G.R. Biella, B. Ruozi, G.F. Tosi, E. Cattaneo
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
2015 M. Valenza, J.Y. Chen, E. Di Paolo, B. Ruozi, D. Belletti, C. Ferrari Bardile, V. Leoni, C. Caccia, E. Brilli, S. Di Donato, M.M. Boido, A. Vercelli, M.A. Vandelli, F. Forni, C. Cepeda, M.S. Levine, G. Tosi, E. Cattaneo
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease
2023 G. Birolini, M. Valenza, I. Ottonelli, F. Talpo, L. Minoli, A. Cappelleri, M. Bombaci, C. Caccia, C. Canevari, A. Trucco, V. Leoni, A. Passoni, M. Favagrossa, M.R. Nucera, L. Colombo, S. Paltrinieri, R. Bagnati, J.T. Duskey, R. Caraffi, M.A. Vandelli, F. Taroni, M. Salmona, E. Scanziani, G. Biella, B. Ruozi, G. Tosi, E. Cattaneo
Connection between astrocytes, cholesterol and synaptic dysfunction in Huntington’s disease
2017 M. Valenza
Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease
2015 M. Valenza, M. Marullo, E. Di Paolo, E. Cesana, C. Zuccato, G. Biella, E. Cattaneo
Dose-dependent and disease-modifying effects of striatal infusion of cholesterol in Huntington{\textquotesingle}s disease
2020 G. Birolini, M. Valenza, E. Dipaolo, E. Vezzoli, F. Talpo, C. Maniezzi, C. Caccia, V. Leoni, V.D. Bocchi, P. Conforti, E. Sogne, L. Petricca, C. Cariulo, M. Verani, A. Caricasole, A. Falqui, G.R. Biella, E. Cattaneo
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease
2005 M. Valenza, D. Rigamonti, D. Goffredo, C. Zuccato, S. Fenu, L. Jamot, A. Strand, A. Tarditi, B. Woodman, M. Racchi, C. Mariotti, S. Di Donato, A. Corsini, G. Bates, R. Pruss, J.M. Olson, S. Sipione, M. Tartari, E. Cattaneo
Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease : a cross-validation study in Q175 knock-in mice
2017 M. Shankaran, E. Di Paolo, V. Leoni, C. Caccia, C. Ferrari Bardile, H. Mohammed, S. Di Donato, S. Kwak, D. Marchionini, S. Turner, E. Cattaneo, M. Valenza
Early transcriptional profiles in huntingtin inducible striatal cells by microarray analyses
2002 S. Sipione, D. Rigamonti, M. Valenza, C. Zuccato, L. Conti, J. Pritchard, C. Kooperberg, J.M. Olson, E. Cattaneo
Early transcriptional profiles in huntingtin-induced striatal cells by microarray analyses
2002 S. Sipione, D. Rigamonti, M. Valenza, C. Zuccato, L. Conti, J. Pritchard, C. Kooperberg, J.M. Olson, E. Cattaneo
Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington's Disease
2020 A. Passoni, M. Favagrossa, L. Colombo, R. Bagnati, M. Gobbi, L. Diomede, G. Birolini, E. Di Paolo, M. Valenza, E. Cattaneo, M. Salmona
Emerging roles for cholesterol in Huntington's disease
2011 M. Valenza, E. Cattaneo